Antidepressants Trial in Parkinson's Disease
Trial
Phase 3
Completed
May 5, 2023
A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD
Trial
Phase 3
Completed
May 5, 2023
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
Trial
Phase 1
Terminated
May 5, 2023
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers
Trial
Phase 1
Completed
May 5, 2023
Rhythmic Auditory Stimulation on Neural Activity During Finger-tapping in PD Patients
Trial
N/A
Unknown
May 2, 2023
Cognitive Control in Parkinson's Disease
Trial
N/A
Completed
May 2, 2023
Optimising Community Resources and Support to Enhance Living With Parkinson's Disease
Trial
N/A
Completed
April 30, 2023
Association Between Fibrinogen-to-albumin Ratio and Delirium After Deep Brain Stimulation Surgery in Parkinson's Disease
Trial
N/A
Completed
April 30, 2023
i-BiSSkApp for Swallowing Rehabilitation in Parkinson's Disease
Trial
Phase 1
Unknown
April 30, 2023
So, they tell me crowds may be a problem…really?
News
Charco Neurotech
April 27, 2023
Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's
Trial
Phase 1
Withdrawn
April 26, 2023
Cerebro Spinal Fluid Collection (CSF)
Trial
N/A
Recruiting
April 26, 2023
Quantification of Beta Activity in Routine EEG Recordings in Parkinson's Disease Patients
Trial
N/A
Completed
April 26, 2023
Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease
Trial
N/A
Completed
April 26, 2023
Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body
Trial
N/A
Unknown
April 24, 2023
Chronic Effects of DBS in Parkinson's Disease and Dystonia
Trial
N/A
Completed
April 23, 2023
Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients With Parkinson's Disease
Trial
N/A
Completed
April 20, 2023
PPMI Tau PET Imaging
Trial
Phase 2
Completed
April 20, 2023
"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"
Trial
N/A
Unknown
April 19, 2023
Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants
Trial
Phase 1
Completed
April 19, 2023